Antihypertensive and safety studies of Cydonia oblonga M

Pak J Pharm Sci. 2021 Mar;34(2(Supplementary)):687-691.

Abstract

Antihypertensive studies on aqueous-methanolic extract prepared from seeds of Cydonia oblonga M. were carried out. The test extract in 200, 400 and 600 mg/kg doses was investigated in normotensive, high cholesterol and glucose fed hypertensive rats through non-invasive blood pressure measuring technique. Acute and sub-chronic toxicity studies were conducted in mice and rats, respectively. The test extract significantly decreased dose dependently the systolic, diastolic and mean arterial pressures. The test extract in 600mg/kg dose produced maximum effect and prevented rise in blood pressure of high cholesterol diet and glucose fed rats as compare to control in 21 days studies. The extract was found safe up to 4g/kg dose in mice. In sub-chronic toxicity study, no significant alteration in blood chemistry of extract treated rats was observed except reduction in the low density cholesterol levels. It is concluded that Cydonia oblonga seeds extract possess antihypertensive effect which supports its use in folklore.

MeSH terms

  • Animals
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Hypertension / drug therapy*
  • Male
  • Mice
  • Plant Extracts / adverse effects
  • Plant Extracts / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Rosaceae / adverse effects
  • Rosaceae / chemistry*
  • Seeds / adverse effects
  • Seeds / chemistry

Substances

  • Antihypertensive Agents
  • Plant Extracts